Bahram Valamehr is Chief R&D Officer of Fate Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
FATE THERAPEUTICS INC
2 Feb 24
4
FATE THERAPEUTICS INC
10 Jan 24
144
FATE THERAPEUTICS INC
9 Jan 24
4
FATE THERAPEUTICS INC
7 Feb 23
4
FATE THERAPEUTICS INC
13 Jan 23
4
FATE THERAPEUTICS INC
11 Jan 23
4
FATE THERAPEUTICS INC
8 Jul 22
4
FATE THERAPEUTICS INC
7 Jul 22
4
FATE THERAPEUTICS INC
15 Mar 22
4
FATE THERAPEUTICS INC
27 Jan 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Jan 24 | FATE Fate Therapeutics | Common Stock | Sell | Dispose S | No | No | 4.38 | 11,271 | 49.37 k | 158,069 |
6 Feb 23 | FATE Fate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 6.77 | 450,000 | 3.05 mm | 450,000 |
12 Jan 23 | FATE Fate Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 1.37 | 423 | 579.51 | 169,340 |
12 Jan 23 | FATE Fate Therapeutics | Stock Option Common Stock | Option exercise | Acquire M | No | No | 1.37 | 423 | 579.51 | 0 |
10 Jan 23 | FATE Fate Therapeutics | Common Stock | Sell | Dispose S | No | No | 5.24 | 10,917 | 57.21 k | 168,917 |